How Your Thyroid Controls Your Testosterone (Check This Before TRT)

Your thyroid is upstream of your testosterone. Not adjacent to it, not loosely connected to it, but structurally upstream in a way that means if the thyroid axis is broken, your testosterone numbers will be low no matter what your testes are capable of producing.

Most men never hear this before they start TRT. This article is going to explain exactly why it matters and what the mechanism looks like at each step.

Your body runs three major hormonal systems and they all share the same control center. The hypothalamus sits at the top of the brain and just below it hangs the pituitary gland, and together they form the relay station for your entire endocrine system. Every axis follows the same pattern: the hypothalamus sends a releasing hormone down to the pituitary, the pituitary sends a stimulating hormone down to a target gland, the target gland produces its hormone, and that hormone feeds back up to the brain to close the loop. The thyroid axis, the testosterone axis, and the growth hormone axis all run this pattern through the same shared infrastructure. That shared infrastructure is what makes them dependent on each other.

Start with the thyroid axis because it is the foundation.

Your hypothalamus releases something called TRH, or thyrotropin releasing hormone, which signals your pituitary to release TSH, or thyroid stimulating hormone, which then travels to your thyroid gland and tells it to make thyroid hormone. Your thyroid produces two things: T4, called thyroxine, which makes up about 80% of output, and T3, called triiodothyronine, which makes up the remaining 20%. T4 is the storage form and T3 is the active form, and T4 has to be converted into T3 by enzymes called deiodinases before your body can actually use it.

Think of T4 as raw material sitting in a warehouse and the deiodinase enzymes as the workers who process that raw material into finished product. If you do not have enough workers, raw material piles up and finished product runs low. Those enzymes require selenium to function, so selenium deficiency directly impairs the conversion step and Winther and colleagues confirmed this in 2020, showing that selenium deficiency produces a high free T4 to T3 ratio, meaning the raw material is there but conversion is failing.

There is also a competing pathway. T4 can get converted into something called reverse T3 instead of active T3, and reverse T3 is biologically inactive. It takes up receptor space without doing anything. Cortisol, specifically chronic elevation of cortisol, activates the enzyme that pushes T4 down the reverse T3 pathway rather than the active T3 pathway, and Chopra and colleagues showed in 1975 that this shift happens within hours of glucocorticoid exposure. So chronic stress does not just suppress testosterone directly. It functionally impairs your thyroid at the conversion step first, and then everything downstream suffers.

Now here is where the connection to testosterone becomes concrete.

Your testosterone axis runs the same relay: the hypothalamus releases GnRH, which signals the pituitary to release LH and FSH, and LH travels to the Leydig cells in your testes and tells them to produce testosterone. Both axes share the same hypothalamus and pituitary, which means your thyroid hormone levels directly influence how well your testosterone axis functions, and there are three distinct mechanisms where this happens.

The first is at the pituitary. T3 modulates how strongly your pituitary responds to the GnRH signal coming from your hypothalamus. In hypothyroidism, the pituitary receives the GnRH signal but produces an inadequate LH response, so the command is being sent but the relay station is not passing it along with full strength. This produces a pattern called hypogonadotropic hypogonadism, which is low testosterone accompanied by low or inappropriately normal LH, meaning the problem is coming from the brain, not from the testes. Donnelly and White demonstrated this in 2000 when they studied men with primary hypothyroidism and found free testosterone nearly doubled, from 161 to 315 pmol/L, after thyroxine replacement. The testes were not the problem. The signal chain was the problem, and restoring thyroid function restored the signal.

The second mechanism is directly at the Leydig cell. Your Leydig cells have thyroid hormone receptors on them and T3 does two things at this level. It increases the number of LH receptors on those cells, making them more sensitive to whatever LH signal they are receiving, and it upregulates something called StAR protein, which stands for steroidogenic acute regulatory protein and which controls the rate-limiting step in testosterone production: the transport of cholesterol into the mitochondria where steroidogenesis begins. Without cholesterol getting into the mitochondria, the factory cannot run. Maran and colleagues showed in 2000 that T3 induced a 260% increase in StAR protein expression in Leydig cells. Your thyroid hormone is not just permitting testosterone production. It is controlling how much raw material enters the process.

The third mechanism involves SHBG, or sex hormone binding globulin, which is a protein your liver produces that binds to testosterone and makes it biologically unavailable. Your thyroid status influences how much SHBG your liver makes, which means that even if your total testosterone number looks acceptable, abnormal thyroid function can shift the ratio of bound to free testosterone in a way that changes what your body can actually use. You cannot interpret a testosterone number without knowing the thyroid context.

Shrivastav and Saboo presented a conference abstract in 2022 looking at 51 men with overt hypothyroidism, and 50% of them had low testosterone at baseline. After levothyroxine treatment normalized thyroid function, 70% of those men had their testosterone return to normal without any testosterone therapy. To be clear, this is a conference abstract from a single center and has not gone through full peer review, so it should be treated as directionally informative rather than definitive. But it is directionally consistent with Donnelly's data and with each of the three mechanisms described above.

The growth hormone axis adds a third layer. Your pituitary contains specialized cells called somatotrophs that release growth hormone, and these cells need adequate T3 to express the receptors that receive the growth hormone releasing signal from the hypothalamus. Miki and colleagues showed in 1989 that hypothyroidism depressed the growth hormone response to GHRH and that T3 treatment restored it. And then there is the peptide angle: compounds like ipamorelin and MK-677 work by targeting something called the growth hormone secretagogue receptor on your pituitary. Kamegai and colleagues showed in 2001 that T3 increases expression of this receptor by extending its mRNA half-life from 8 hours to 15 hours, essentially keeping the receptor around longer so more of it is available. That study was done in rat pituitary cells so direct human confirmation does not exist yet, but the mechanism means that suboptimal thyroid function may reduce the receptor density that peptides depend on to work.

The order of operations is: thyroid first, testosterone second, growth hormone third.

So what should bloodwork actually include before anyone considers TRT or peptide protocols? TSH alone misses the problem entirely. Your TSH can sit in the normal range while your free T3 is low and your reverse T3 is elevated, a pattern sometimes called functional hypothyroidism where the gland appears fine but conversion is failing downstream. A complete panel means TSH, free T3, free T4, and reverse T3 for the thyroid axis, and total testosterone, free testosterone, LH, and SHBG for the testosterone axis. LH is the variable that tells you whether you are dealing with primary hypogonadism, meaning the testes themselves are failing, or secondary hypogonadism, meaning the signal chain is failing, which is the version that thyroid dysfunction produces.

If the panel shows suboptimal thyroid function before any true pathology, there are nutritional levers worth addressing first. Selenium at 200 micrograms daily supports the deiodinase enzymes responsible for T4 to T3 conversion, and staying below 400 micrograms matters because selenium has a narrow therapeutic window. Zinc at 30 milligrams daily is required for both TRH synthesis and thyroid hormone receptor function, which makes it relevant to the thyroid axis and the testosterone axis simultaneously. Iron is a component of thyroid peroxidase, the enzyme your thyroid needs to produce T4 and T3 in the first place, and Hess and colleagues showed that iron deficiency reduced thyroid peroxidase activity by 33 to 56% in rats, so ferritin should be part of any complete workup. Iodine is the structural building block of thyroid hormones but excess iodine can worsen autoimmune thyroid conditions, so supplementation only makes sense if deficiency has actually been confirmed.

When the bloodwork shows true hypothyroidism with elevated TSH and low T4 and T3, or when the cause is Hashimoto's thyroiditis which is autoimmune and cannot be corrected with nutritional support, levothyroxine under medical supervision is the appropriate next step. Over-replacement carries real consequences including bone loss, atrial fibrillation, and anxiety, which is why working with an endocrinologist who runs the full panel rather than just TSH makes a meaningful difference.

The deeper point here is this: when a man comes in with low testosterone, the question is not simply whether his testosterone is low. The question is where in the chain the signal is breaking down, and that answer requires looking upstream. A system that skips the thyroid panel and goes straight to TRT is not diagnosing the problem. It is treating a number while leaving the actual cause in place.

Fix the foundation and the things built on it start working. That is not a metaphor. That is the mechanism.

---

References

1. Donnelly P, White C. 2000. Testicular dysfunction in men with primary hypothyroidism; reversal of hypogonadotrophic hypogonadism with replacement thyroxine. Clinical Endocrinology, 522:197-201. Free testosterone nearly doubled 161 to 315 pmol/L after thyroxine replacement in hypothyroid men. Source
2. Shrivastav A, Saboo B. 2022. Effect of levothyroxine replacement therapy on testosterone, LH, FSH levels in men with overt hypothyroidism. ECE2022 Conference Abstract, Endocrine Abstracts, 81, P730. 70% of hypogonadal hypothyroid patients had testosterone normalize after levothyroxine. Conference abstract, N=51. Source
3. Maran RR, et al. 2000. Assessment of mechanisms of thyroid hormone action in mouse Leydig cells. Endocrinology, 14112:4468-4477. T3 increases LH receptor numbers, StAR protein 260% increase, and steroidogenic enzyme expression in Leydig cells. Source
4. Kamegai J, et al. 2001. Thyroid hormones regulate pituitary growth hormone secretagogue receptor gene expression. Journal of Neuroendocrinology, 133:275-278. T3 increased GHS-R mRNA by extending half-life from 8h to 15h in rat pituitary cells. Source
5. Miki N, et al. 1989. Effects of hypothyroidism, T3 and glucocorticoids on GH responses to GHRH. Journal of Endocrinology, 122:585-591. Hypothyroidism depressed growth hormone response to GHRH; T3 treatment restored it. Source
6. Winther KH, et al. 2020. Thyroid function in patients with selenium deficiency exhibits high free T4 to T3 ratio. BMC Endocrine Disorders. Selenium deficiency directly associated with impaired T4 to T3 conversion. Source
7. Hess SY, et al. 2002. Iron deficiency anemia reduces thyroid peroxidase activity in rats. Journal of Nutrition, 1327:1951-1955. Iron deficiency reduced TPO activity by 33-56%. Source
8. Chopra IJ, et al. 1975. Opposite effects of dexamethasone on serum concentrations of reverse T3 and T3. Journal of Clinical Endocrinology and Metabolism. Cortisol shifts T4 metabolism toward reverse T3 within hours. Source

---

Join the free community:
Men: Iron Forge Brotherhood
Women: Powerhouse Fitness